bioMérieux

bioMérieux

Recherche en biotechnologie

Marcy-l'Étoile, Auvergne-Rhône-Alpes 319 692 abonnés

Pioneering Diagnostics

À propos

Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP

Site web
https://www.biomerieux.com
Secteur
Recherche en biotechnologie
Taille de l’entreprise
+ de 10 000 employés
Siège social
Marcy-l'Étoile, Auvergne-Rhône-Alpes
Type
Société cotée en bourse
Fondée en
1963
Domaines
in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank et sepsis

Lieux

Employés chez bioMérieux

Nouvelles

  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    Celebrating Excellence at bioMérieux! ✨ Recently, we welcomed our 2023 Chairman’s Circle and bioSTAR award winners to France for two special week-long events! 🙌 Our top sales performers and premier channel partners were celebrated during two exclusive events designed to recognize and reward their outstanding achievements, foster connections with colleagues and leaders, highlight our unique history of innovation, and strengthen the bioMérieux global community – all while enjoying the cuisine and culture of France! Congratulations to all the winners! You are truly elevating the experience we deliver to our valued customers and boldly contributing to our mission to help make the world a healthier place! 👏 #WeArebioMérieux

    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    At bioMérieux, developing our team members is a priority. 💡 Training sessions, educational meetings, feedback culture and engagement programs: we use various levers to help our 14,600 talents worldwide develop their knowledge and skills. In 2023, we focused our efforts on soft skills, as well as on #Diversity and #Inclusion (D&I). 👉 Learn more about these internal development programs in our 2023 Annual Report: http://spkl.io/604647qUs #WeArebioMérieux

  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    🥳 What a Day! On June 27th, we hosted our French Annual Meeting, bringing together 3700 team members from across our French sites! Live from the Halle Tony Garnier in Lyon and the Château des Pères in Rennes, we shared our impactful achievements over the past year and looked at our perspectives for the years to come through the lenses of our new strategic plan GO•28. A perfect way to celebrate the remarkable dedication and hard work of each and every one of our team members. 👏 A special thanks to Fanfare Express for filling the day with music and to Sadeck Berrabah for getting us all to dance together! 🎶 #WeArebioMérieux 📸© Franck Levey & Florent Dubray 📷

    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
      +4
  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    Nearly 47% of the world population lacks access to essential diagnostic tools, which are critical for effective healthcare, prevention, and treatment. 👉 To address this life-threatening issue, we actively participate in international programs through our Global Health Department to facilitate the provision of sustainable diagnostic tools and associated support to developing countries. That's why we also create solutions for labs of any size, ensuring that our innovations reach even the most resource-limited settings. 🔎 Read more about our Global Health approach in our 2023 Annual Report: https://lnkd.in/e2h9QvST #PioneeringDiagnostics

  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    🌍 Our first Supplier Virtual Summit "Go Responsible: Collaborative Impact for #Climate" hosted last month was a great success! We recorded more than 700 live connections, showcasing the dedication and enthusiasm of our supplier community in addressing pressing climate challenges together. 👏 They could participate in the insightful keynote by the renowned glaciologist Dr. Heïdi Sevestre, whose expertise and passion inspired us all. On June 5th, for World Environment Day, they could listen to our executive leaders, Valerie Leylde and Pierre Boulud, share our ambition for the future, and testimonials from our internal and external stakeholders. Several workshops were also held to share best practices, answer questions and develop collaborative action plans to reduce our carbon footprint. 👉 Representing 85% of the greenhouse gas emissions related to our goods and services, we are proud to work hand in hand with 350 of our #partners from all over the world for a more sustainable future! Their active participation and continuous commitment are vital as we speed up our efforts to implement environmentally responsible actions to preserve the planet as a healthy place to live. A big thank you to all our partners for their commitment and contribution. Let's stay engaged and continue working together for a positive impact. 💪 #WeArebioMérieux #WeActForAPositiveImpact

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    🎥 Curious about what drives a bioMérieux Lab Transformation team? Meet Stephanie, Lab Transformation Manager, and Janhendrik, Operational Excellence Consultant from Germany! Every day, they work on optimizing lab processes and implementing automation to deliver optimal solutions for clients across Europe. 🤝 Stephanie and Janhendrik collaborate with customers and internal teams to smoothly integrate new technologies. See how they use creativity, adapt to project changes, and achieve excellence through teamwork! 👇 #WeArebioMérieux

  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    📢 We are announcing today that the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments). The BIOFIRE® SPOTFIRE® R/ST Panel Mini is a unique multiplex PCR test that detects 5 of the most common viral and bacterial causes of respiratory or sore throat infections in about 15 minutes. 💡 More and more tests are carried out outside hospital labs directly in Emergency Departments or at the Point of Care. This market is particularly active in the United States. A fast and innovative syndromic testing solution, the BIOFIRE® SPOTFIRE® range perfectly matches these new medical needs, close to patients. 📰 Read the full press release: https://lnkd.in/gJCJZpaM #PioneeringDiagnostics

    • We are announcing today that the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments).
  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    📢 We are announcing today that our VITEK® REVEAL™ AST System, reporting results directly from positive blood cultures, has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The modular VITEK® REVEAL™ AST system can deliver actionable results for gram-negative bacteria directly from positive blood cultures in an average of 5.5-6 hours enabling same-day treatment decision-making for patients suffering from bacteremic sepsis. For clinicians to rapidly optimize therapy and improve patient care, fast and accurate antimicrobial susceptibility testing (AST) results and interpretation are critical. Fast AST play a key role too in the fight against antimicrobial resistance. 📰 Read the full press release: https://lnkd.in/gRvw-PxY #PioneeringDiagnostics

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour bioMérieux, visuel

    319 692  abonnés

    👨💻 Data/IT science and Artificial Intelligence are revolutionizing diagnostics. The tools linked to data management, information technology and artificial intelligence are useful for better understanding and to further the knowledge of traditional biology, through the use of large databases, sophisticated algorithms, and cloud computing. 💡 Two of our data scientists, Brooklyn Noble and Maxime Bodinier discuss the changes and promises provided by Data/IT and #AI solutions in 2023 Annual Report: https://lnkd.in/e88wDtz6 #PioneeringDiagnostics

Pages affiliées

Pages similaires

Parcourir les offres d’emploi